Drug Monitoring, Novel Psychoactive Substances (NPS), Qualitative, Urine
Test Code
Clinical Significance
Drug Monitoring, Novel Psychoactive Substances (NPS), Qualitative, Urine - Novel psychoactive substances (NPS) are compounds designed to mimic the effects of prescription drugs, evade detection by typical drug testing methodologies, and avoid regulation. NPS can also be referred to as legal highs, Spice, Benzo Dope, Tranq Dope, or in products labelled "not for human use". NPS markets rapidly change in response to regulation from national and international agencies. These drugs are not typically detected by presumptive, immunoassay point-of-care or desktop analyzer drug tests. NPS may potentiate drug interactions with prescription medications, leading to unintended overdoses. ...
Test Resources
Test Details
Designer Fentanyl Analogs
Designer Opioids
Designer Stimulants
Synthetic Cannabinoids
Other Illicit Additives
NPS Comments will be automatically added
Methodology
Reference Range(s)
| Designer Benzodiazepines | <10 ng/mL |
| Designer Fentanyl Analogs | <10 ng/mL |
| Designer Opioids | <10 ng/mL |
| Designer Stimulants | <10 ng/mL |
| Synthetic Cannabinoids | <10 ng/mL |
| Other Illicit Additives | <20 ng/mL |
Alternative Name(s)
Preferred Specimen(s)
3 mL urine
Minimum Volume
2 mL
Transport Container
Plastic urine container
Transport Temperature
Room temperature
Specimen Stability
- Room temperature: 7 days
Refrigerated: 14 days
Frozen: 30 days
Reject Criteria
Preserved samples
Setup Schedule
Refrigerated: 14 days
Frozen: 30 days